My site

HIGH POINT, N.C. - Saturday, November 3rd 2012 [ME NewsWire]

(BUSINESS WIRE)-- TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents. TTP054 acts as an agonist of the glucagon-like peptide 1 receptor (GLP1r).

"Currently available anti-diabetic agents fall short in controlling diabetes in a large percentage of the affected population. Therefore, the search for novel drugs and mechanisms to address this huge unmet medical need is imperative,” said Dr. Adnan Mjalli, Chairman and CEO of TransTech Pharma. "Injectable GLP-1 analogues, have shown impressive efficacy in the treatment of type 2 diabetes but are associated with several side effects, including naus ... Read more »

BUSINESS WIRE / ME NewsWire MCLEAN, Va. - Thursday, November 1st 2012

Today, on World Food Day, Hilton Worldwideannounced multi-year partnerships with Feeding Americaand The Global FoodBanking Networkto secure food and reduce hunger in communities where it operates around the globe. The collaborations will enable Hilton Worldwide hotels to collect safe, surplus food from conferences and daily food and beverage operations that would otherwise be thrown away and make it available to those in need.

Feeding America and The Global FoodBanking Network will each connect Hilton Worldwide hotels with local food banks and their networks of local community agencies to facilitate food delivery to school feeding programs, food pantries, soup kitchens, hospices, after-school programs and other community programs that provide food to families in need of nourishing meals. In year one, Hilton Worldwide will pilot food donation systems in New York City, Washington, D.C., Chicago, San Fran ... Read more »